190 related articles for article (PubMed ID: 38814099)
1. Visible and Red Light-Triggered Anticancer Profile of a Ferrocene-Re(I)-Tricarbonyl Conjugate: Experimental and Theoretical Studies.
Kushwaha R; Upadhyay A; Peters S; Yadav AK; Mishra A; Bera A; Sadhukhan T; Banerjee S
Langmuir; 2024 Jun; 40(23):12226-12238. PubMed ID: 38814099
[TBL] [Abstract][Full Text] [Related]
2. LMCT transition-based red-light photochemotherapy using a tumour-selective ferrocenyl iron(iii) coumarin conjugate.
Sarkar T; Bhattacharyya A; Banerjee S; Hussain A
Chem Commun (Camb); 2020 Jul; 56(57):7981-7984. PubMed ID: 32538387
[TBL] [Abstract][Full Text] [Related]
3. Design of a Tris-Heteroleptic Ru(II) Complex with Red-Light Excitation and Remarkably Improved Photobiological Activity.
Li S; Zhao J; Wang X; Xu G; Gou S; Zhao Q
Inorg Chem; 2020 Aug; 59(15):11193-11204. PubMed ID: 32702972
[TBL] [Abstract][Full Text] [Related]
4. π-Expansive Heteroleptic Ruthenium(II) Complexes as Reverse Saturable Absorbers and Photosensitizers for Photodynamic Therapy.
Wang L; Yin H; Jabed MA; Hetu M; Wang C; Monro S; Zhu X; Kilina S; McFarland SA; Sun W
Inorg Chem; 2017 Mar; 56(6):3245-3259. PubMed ID: 28263079
[TBL] [Abstract][Full Text] [Related]
5. Ruthenium(II) Conjugates of Boron-Dipyrromethene and Biotin for Targeted Photodynamic Therapy in Red Light.
Paul S; Kundu P; Bhattacharyya U; Garai A; Maji RC; Kondaiah P; Chakravarty AR
Inorg Chem; 2020 Jan; 59(1):913-924. PubMed ID: 31825210
[TBL] [Abstract][Full Text] [Related]
6. Curcumin "Drug" Stabilized in Oxidovanadium(IV)-BODIPY Conjugates for Mitochondria-Targeted Photocytotoxicity.
Bhattacharyya U; Kumar B; Garai A; Bhattacharyya A; Kumar A; Banerjee S; Kondaiah P; Chakravarty AR
Inorg Chem; 2017 Oct; 56(20):12457-12468. PubMed ID: 28972748
[TBL] [Abstract][Full Text] [Related]
7. Ferrocene-Appended Iridium(III) Complexes: Configuration Regulation, Anticancer Application, and Mechanism Research.
Ge X; Chen S; Liu X; Wang Q; Gao L; Zhao C; Zhang L; Shao M; Yuan XA; Tian L; Liu Z
Inorg Chem; 2019 Oct; 58(20):14175-14184. PubMed ID: 31559820
[TBL] [Abstract][Full Text] [Related]
8. A mitochondrion-targeted BODIPY-Ir(III) conjugate as a photoinduced ROS generator for the oxidative destruction of triple-negative breast cancer cells.
Qiao L; Liu J; Kuang S; Liao X; Kou J; Ji L; Chao H
Dalton Trans; 2021 Oct; 50(40):14332-14341. PubMed ID: 34558567
[TBL] [Abstract][Full Text] [Related]
9. Photophysical Properties and Photobiological Activities of Ruthenium(II) Complexes Bearing π-Expansive Cyclometalating Ligands with Thienyl Groups.
McCain J; Colón KL; Barrett PC; Monro SMA; Sainuddin T; Roque Iii J; Pinto M; Yin H; Cameron CG; McFarland SA
Inorg Chem; 2019 Aug; 58(16):10778-10790. PubMed ID: 31386351
[TBL] [Abstract][Full Text] [Related]
10. BODIPY-attached zinc(II) complexes of curcumin drug for visible light assisted photo-sensitization, cellular imaging and targeted PDT.
Bhattacharyya A; Jameei A; Karande AA; Chakravarty AR
Eur J Med Chem; 2021 Aug; 220():113438. PubMed ID: 33915370
[TBL] [Abstract][Full Text] [Related]
11. Oxoplatin-B, a cisplatin-based platinum(IV) complex with photoactive BODIPY for mitochondria specific "chemo-PDT" activity.
Bera A; Gautam S; Raza MK; Kondaiah P; Chakravarty AR
J Inorg Biochem; 2021 Oct; 223():111526. PubMed ID: 34246120
[TBL] [Abstract][Full Text] [Related]
12. New Selenonapthaquinone-Based Copper (II) Complexes as the Next-Generation Photochemotherapeutic Agents.
Devi LR; Raza MK; Musib D; Roy M
Anticancer Agents Med Chem; 2021; 21(1):33-41. PubMed ID: 32720606
[TBL] [Abstract][Full Text] [Related]
13. Photo-physical, theoretical and photo-cytotoxic evaluation of a new class of lanthanide(iii)-curcumin/diketone complexes for PDT application.
Musib D; Pal M; Raza MK; Roy M
Dalton Trans; 2020 Aug; 49(31):10786-10798. PubMed ID: 32779686
[TBL] [Abstract][Full Text] [Related]
14. Photophysical and Photobiological Properties of Dinuclear Iridium(III) Bis-tridentate Complexes.
Liu B; Monro S; Lystrom L; Cameron CG; Colón K; Yin H; Kilina S; McFarland SA; Sun W
Inorg Chem; 2018 Aug; 57(16):9859-9872. PubMed ID: 30091916
[TBL] [Abstract][Full Text] [Related]
15. Ferrocene-modified half-sandwich iridium(III) and ruthenium(II) propionylhydrazone complexes and anticancer application.
Ji C; Dong R; Zhang P; Tao R; Wang X; Dai Q; Liu X; Yuan XA; Zhang S; Yue M; Liu Z
J Inorg Biochem; 2024 Aug; 257():112586. PubMed ID: 38728860
[TBL] [Abstract][Full Text] [Related]
16. Comparative Study of Sonodynamic and Photoactivated Cancer Therapies with Re(I)-Tricarbonyl Complexes Comprising Phenanthroline Ligands.
Kushwaha R; Singh V; Peters S; Yadav AK; Sadhukhan T; Koch B; Banerjee S
J Med Chem; 2024 Apr; 67(8):6537-6548. PubMed ID: 38603561
[TBL] [Abstract][Full Text] [Related]
17. Maloplatin-B, a Cisplatin-Based BODIPY-Tagged Mito-Specific "Chemo-PDT" Agent Active in Red Light.
Ramu V; Kundu P; Kondaiah P; Chakravarty AR
Inorg Chem; 2021 May; 60(9):6410-6420. PubMed ID: 33843212
[TBL] [Abstract][Full Text] [Related]
18. Extending the Excitation Wavelength of Potential Photosensitizers via Appendage of a Kinetically Stable Terbium(III) Macrocyclic Complex for Applications in Photodynamic Therapy.
Ung P; Clerc M; Huang H; Qiu K; Chao H; Seitz M; Boyd B; Graham B; Gasser G
Inorg Chem; 2017 Jul; 56(14):7960-7974. PubMed ID: 28682604
[TBL] [Abstract][Full Text] [Related]
19. Polymeric Encapsulation of Novel Homoleptic Bis(dipyrrinato) Zinc(II) Complexes with Long Lifetimes for Applications as Photodynamic Therapy Photosensitisers.
Karges J; Basu U; Blacque O; Chao H; Gasser G
Angew Chem Int Ed Engl; 2019 Oct; 58(40):14334-14340. PubMed ID: 31386250
[TBL] [Abstract][Full Text] [Related]
20. Ruthenium-Cathepsin Inhibitor Conjugates for Green Light-Activated Photodynamic Therapy and Photochemotherapy.
Denison M; Garcia SP; Ullrich A; Podgorski I; Gibson H; Turro C; Kodanko JJ
Inorg Chem; 2024 Apr; 63(17):7973-7983. PubMed ID: 38616353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
